Molecules/PATRITUMAB

PATRITUMAB

Molecular Identity

AntibodyPhase 3

Mechanism of action: Receptor tyrosine-protein kinase erbB-3 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

AMG 888PatritumabPATRITUMABU3-1287

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to PATRITUMAB

Loading drug network...